开发和验证基于微信小应用程序的查工具 (eR-BFAS),用于早期检测帕金森病
Yongyi Cai1, Henhui Tan2, Sibo Peng2
1The Second School of Clinical Medicine, Southern Medical University, 253 Gongye Avenue, Guangzhou, Guangdong, 510282, P.R. China.
Aging clinical and experimental research
|July 9, 2025
概括
一个新的微信迷你应用程序eR-BFAS通过评估运动和非运动症状,有效地选早期帕金森病 (PD). 这种可访问的工具有助于及时检测和介入PD.
科学领域:
- 神经学 神经学
- 数字健康数字健康
- 老年学是一门学科.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,需要早期检测才能获得最佳的患者结果.
- 目前的PD查方法通常是复杂的,缺乏可访问性,特别是在老年人群中.
研究的目的:
- 开发和验证一种新的基于微信小应用程序的查工具eR-BFAS,用于早期检测帕金森病.
- 该eR-BFAS将运动症状与睡眠障碍和低血症的非运动评估相结合.
主要方法:
- 该eR-BFAS工具是通过结合贝勒功能评估屏幕 (BFAS),快速眼动睡眠行为障碍查问卷 (RBDSQ) 和缺血症评分表 (HRS) 来创建的.
- 该工具通过微信部署,参与者自我评估症状;随后的随访确定了最终诊断.
- 统计分析包括确认因素分析,内部一致性,测试重试可靠性和诊断性能的评估.
主要成果:
- 24项的eR-BFAS表现出强大的内部一致性 (克朗巴赫α = 0.875) 和出色的测试-重新测试可靠性 (ICC = 0.927).
- 确认因素分析证实了良好的结构有效性 (χ2 / df = 1.573,RMSEA = 0.064,CFI = 0.927). 这是一个非常好的方法.
- 该eR-BFAS实现了87.9%的预测准确度,灵敏度为86.7%,特异性为88.9%,最佳截止分数为27.
结论:
- eR-BFAS是用于查早期帕金森病的可靠和有效工具,它结合了运动和非运动症状.
- 利用微信的广泛可访问性,这个数字工具显示了促进PD早期检测和社区环境中的干预的巨大潜力.
关键词:
贝勒功能评估屏幕 (BFAS) 规模表格.低血症评级尺度 (HRS) 是一个低血症评级尺度.非运动症状 非运动症状帕金森氏症的疾病.快速眼动睡眠行为障碍查问卷 (RBDSQ) 尺度我们的微信应用程序是微信.更多相关视频
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
8.0K
08:42Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
Published on: July 18, 2008
16.2K
相关概念视频
Parkinson's Disease: Treatment
389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
Parkinson's Disease: Overview
716
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
716
